FDA Approved: PREMARIN VAGINAL — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Premarin Vaginal (conjugated estrogens), resulting in a labeling update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar and Vaginal Atrophy Due to Menopause

Drugs mentioned

• PREMARIN VAGINAL (Conjugated estrogens)

Snippet

SUPPL AP for PREMARIN VAGINAL (CONJUGATED ESTROGENS)